# Validation of Biomarkers

**Funder:** KWF
**Budget:** €0.8M–€2M
**Deadline:** 20 October 2026 (Pre-proposal deadline: 20 October 2026 at 12:00 noon. Full proposal deadline: 23 February 2027 at 12:00 noon.)
**Duration:** 2-5 years
**Consortium:** Required — minimum 4 participating parties (may include private partners)
**Application:** 2-stage: pre-proposal (opens 25 Aug 2026, closes 20 Oct 2026) → full proposal (opens 15 Dec 2026, closes 23 Feb 2027), followed by interviews in May 2027
**TRL:** 5-6
**Frequency:** Annual
**Eligible countries:** NL
**Official call:** https://www.kwf.nl/en/forresearchers/funding/validation-of-biomarkers-2027
**Last verified:** 5 July 2026

## Eligibility & scope

Clinical validation of known oncology biomarkers (TRL5/6) for use in daily clinical practice. Requires multidisciplinary consortium of ≥4 parties including biostatistician and HTA expert; patient involvement is mandatory. AI-component projects must engage the AI4HEALTH consortium. Proposals submitted via KWF GMS; Dutch-based institutions expected.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-validation-of-biomarkers-2026-10) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.